5 Biggest Neuroscience Companies in the World

2. AbbVie Inc. (NYSE:ABBV)

Market Cap as of January 07, 2023: $294.54 billion

Founded in 2013, AbbVie Inc. (NYSE:ABBV) is a specialty biopharmaceutical corporation that operates in the discovery, development, manufacturing, and commercialization of drugs to treat chronic and complex disorders. The neuroscience segment of the company is focused on research and development of therapies to treat neurological disorders such as Alzheimer’s, major depressive disorder, bipolar disorder,  migraine, stroke, post-stroke spasticity, Parkinson’s, schizophrenia, and other disorders related to the central nervous system. Namzaric, Depakote, Requip, and Zinbryta are examples of some of the company’s products.